TickerFacts.

Burning Rock Biotech Ltd (BNR): Total Liabilities

Annual figures by period end, from SEC filings.

285.11M CNY
As of 2025-12-31
-12.7%
3-year compound annual growth
+3.3%
5-year compound annual growth
433.28M CNY2019-12-31: 212.02M CNY2020-12-31: 242.02M CNY2021-12-31: 433.28M CNY2022-12-31: 429.13M CNY2023-12-31: 271.59M CNY2024-12-31: 304.48M CNY2025-12-31: 285.11M CNY285.11M CNY
2019-12-31 Total Liabilities (CNY) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31285.11M CNY-6.4%2026-04-28, Balance as of period end
2024-12-31304.48M CNY+12.1%2026-04-28, Balance as of period end
2023-12-31271.59M CNY-36.7%2025-04-29, Balance as of period end
2022-12-31429.13M CNY-1.0%2024-04-29, Balance as of period end
2021-12-31433.28M CNY+79.0%2023-04-20, Balance as of period end
2020-12-31242.02M CNY+14.2%2022-04-29, Balance as of period end
2019-12-31212.02M CNYn/a2021-03-23, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31285.11M CNY-6.4%
Concord Medical Services Holdings Ltd (CCM)2025-12-314.70B CNY-8.1%

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗